Clinical Status & Identity
Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injectable Product
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.
Source & Registry Data
Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_261102F
The specific version of the vocabulary provided by the source.
Update Date
November 02, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
Technical Attributes & Logic
RXN AVAILABLE STRENGTH
0.0075 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2) / 0.0075 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.01 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.025 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273) / 0.025 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.025 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2) / 0.025 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.0333 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (KP.2))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.0333 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.0333 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273) / 0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (BA.4/BA.5))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2) / 0.05 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (BA.4/BA.5))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.1 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.1 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (LP.8.1))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.1 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.1 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1))
Available drug strengths listed in the order of ingredients from the drug
RXN AVAILABLE STRENGTH
0.1 MG/ML (expressed as SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1))
Available drug strengths listed in the order of ingredients from the drug